- Total Q3 revenue rose 26% year-over-year to $4,213M driven by Pharmacy Solutions (+26%) and Provider Services (+31%)
- Adjusted EBITDA increased 42% YoY to $228M; GAAP net income and EPS expanded significantly
- Management raised full-year 2026 revenue and Adjusted EBITDA guidance
?? Positive AI Sentiment (+6.8 / 10)